{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:02:35Z","timestamp":1747162955245,"version":"3.40.5"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vice Chancellor for Research and Technology, Kermanshah University of Medical Sciences","award":["91398"],"award-info":[{"award-number":["91398"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.intimp.2016.11.035","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T06:18:41Z","timestamp":1481091521000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-1553","authenticated-orcid":false,"given":"Fatemeh","family":"Khademi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mostafaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Gholami Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantea","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.11.035_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000082102","article-title":"The biology of CD20 and its potential as a target for mAb therapy","volume":"8","author":"Cragg","year":"2005","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.intimp.2016.11.035_bb0010","first-page":"17","article-title":"CD20: a gene in search of a function","volume":"27","author":"Riley","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/gcc.2870110407","article-title":"Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC","volume":"11","author":"Galiegue-Zouitina","year":"1994","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.intimp.2016.11.035_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0167-5699(94)90273-9","article-title":"Molecular mechanisms regulating CD19, CD20 and CD22 gene expression","volume":"15","author":"Kehrl","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.intimp.2016.11.035_bb0025","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.molimm.2007.06.151","article-title":"Mechanisms of killing by anti-CD20 monoclonal antibodies","volume":"44","author":"Glennie","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0030","article-title":"Anti-CD20 monoclonal antibody","author":"Numazaki","year":"2012","journal-title":"Google Patents"},{"key":"10.1016\/j.intimp.2016.11.035_bb0035","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1182\/blood-2002-02-0469","article-title":"In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas","volume":"101","author":"Manches","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0045","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2165\/11319270-000000000-00000","article-title":"Current and emerging treatments for chronic lymphocytic leukaemia","volume":"69","author":"Robak","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0050","first-page":"251","article-title":"CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma","volume":"67","author":"van Meerten","year":"2009","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.intimp.2016.11.035_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.11.035_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/mabs.26761","article-title":"An improved and robust DNA immunization method to develop antibodies against extracellular loops of multi-transmembrane proteins","volume":"6","author":"Hazen","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/mabs.2.3.11676","article-title":"Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization","volume":"2","author":"Martin-Folgar","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0070","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4049\/jimmunol.160.3.1458","article-title":"Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor","volume":"160","author":"Costagliola","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(02)00115-7","article-title":"Use of DNA immunization to produce polyclonal antibodies against the native human neurokinin-1 receptor for substance P","volume":"128","author":"Tymciu","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vascn.2007.11.002","article-title":"Generation of polyclonal antibodies directed against G protein-coupled receptors using electroporation-aided DNA immunization","volume":"58","author":"Kaptein","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.intimp.2016.11.035_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(03)00192-3","article-title":"DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins","volume":"280","author":"Nagata","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2016.11.035_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/HAB-2009-0205","article-title":"Production of human antibodies to native cytokine receptors using the genetic immunization of KM mice","volume":"18","author":"Fujimoto","year":"2009","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.intimp.2016.11.035_bb0095","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/dna.2011.1239","article-title":"Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor","volume":"30","author":"Allard","year":"2011","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0100","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/endo.142.8.8301","article-title":"Naked TSH receptor DNA vaccination: a TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice","volume":"142","author":"Pichurin","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2016.11.035_bb0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2144\/000112088","article-title":"Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA","volume":"40","author":"Bates","year":"2006","journal-title":"BioTechniques"},{"key":"10.1016\/j.intimp.2016.11.035_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/104454904323145281","article-title":"Enhancement of antibody responses in DNA vaccination using a vector encoding a universal T-helper cell epitope","volume":"23","author":"Tymciu","year":"2004","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2008.10.017","article-title":"Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: a comparison between DNA and protein immunizations","volume":"341","author":"Alexandrenne","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2016.11.035_bb0120","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.intimp.2016.11.035_bb0125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1089\/hum.1994.5.11-1335","article-title":"Humoral and cellular immunity to an encoded protein induced by direct DNA injection","volume":"5","author":"Katsumi","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.intimp.2016.11.035_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(97)01201-2","article-title":"Gene vaccination: plasmid DNA is more than just a blueprint","volume":"19","author":"Tighe","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.intimp.2016.11.035_bb0135","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1073\/pnas.051630798","article-title":"Intralymphatic immunization enhances DNA vaccination","volume":"98","author":"Maloy","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.11.035_bb0140","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1128\/JVI.74.24.11598-11607.2000","article-title":"Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer","volume":"74","author":"Zucchelli","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0145","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1073\/pnas.94.26.14626","article-title":"DNA immunization: induction of higher avidity antibody and effect of route on T cellcytotoxicity","volume":"94","author":"Boyle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.11.035_bb0150","first-page":"5480","article-title":"CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2016.11.035_bb0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood-2002-06-1761","article-title":"Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts","volume":"101","author":"Cragg","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0160","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1182\/blood-2003-06-2031","article-title":"Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents","volume":"103","author":"Cragg","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00003495-200666060-00005","article-title":"Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"66","author":"Cvetkovic","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0170","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1200\/JCO.2008.19.9117","article-title":"Humanized anti-CD20 antibody, veltuzumab, in refractory\/recurrent non-Hodgkin's lymphoma: phase I\/II results","volume":"27","author":"Morschhauser","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0175","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/art.23732","article-title":"Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I\/II randomized, blinded, placebo-controlled, dose-ranging study","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2016.11.035_bb0180","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1182\/blood-2007-10-117671","article-title":"First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1\/2 trial","volume":"111","author":"Hagenbeek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0185","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1182\/blood-2008-04-149161","article-title":"Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation","volume":"112","author":"Beers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0190","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1182\/blood-2009-06-225979","article-title":"Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity","volume":"115","author":"Mossner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/11539590-000000000-00000","article-title":"New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies","volume":"25","author":"Robak","year":"2011","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0200","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1200\/JCO.2000.18.17.3135","article-title":"Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment","volume":"18","author":"Davis","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/sonc.2002.30152","article-title":"Rituximab in combination with CHOP or fludarabine in low-grade lymphoma","volume":"29","author":"Czuczman","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/cbr.1997.12.177","article-title":"Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs","volume":"12","author":"Demidem","year":"1997","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.intimp.2016.11.035_bb0215","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V100.5.1765.h81702001765_1765_1773","article-title":"Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects","volume":"100","author":"Rose","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0220","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0225","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0230","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0240","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/intimm\/9.12.1897","article-title":"Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization","volume":"9","author":"Boyle","year":"1997","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0245","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.clinbiochem.2009.05.019","article-title":"Purification of three major forms of beta-hCG from urine and production of polyclonal antibodies against them","volume":"42","author":"Khademi","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.intimp.2016.11.035_bb0250","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/hyb.2012.0062","article-title":"A high affinity monoclonal antibody recognizing the light chain of human coagulating factor VII","volume":"31","author":"Sarial","year":"2012","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.intimp.2016.11.035_bb0255","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2016.11.035_bb0260","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.11.035_bb0265","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/j.1460-2075.1988.tb02867.x","article-title":"Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains","volume":"7","author":"Einfeld","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2016.11.035_bb0270","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V69.2.584.584","article-title":"Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas","volume":"69","author":"Press","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0003-2697(86)90207-1","article-title":"Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on western blots by monoclonal antibodies","volume":"157","author":"Dunn","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2016.11.035_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.icb.7100004","article-title":"Positive reactions on western blots do not necessarily indicate the epitopes on antigens are continuous","volume":"85","author":"Zhou","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0285","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/JVI.74.12.5548-5555.2000","article-title":"Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein","volume":"74","author":"Schofield","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0290","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.vaccine.2003.12.017","article-title":"An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4","volume":"22","author":"Zhou","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2016.11.035_bb0295","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.11.035_bb0300","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood.V95.12.3900","article-title":"Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis","volume":"95","author":"Golay","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2016.11.035_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2454-6798.180581","article-title":"An update on newer monoclonal antibodies in lymphoma therapy","volume":"2","author":"Kadavakolan","year":"2016","journal-title":"Asian J. Oncol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4161\/mabs.22771","article-title":"Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties","volume":"5","author":"Klein","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2016.11.035_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/153685904322771980","article-title":"Monoclonal antibody against mouse CAR following genetic immunization","volume":"23","author":"Carson","year":"2004","journal-title":"Hybrid. Hybridomics"},{"key":"10.1016\/j.intimp.2016.11.035_bb0320","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/icb.2009.4","article-title":"Monoclonal antibodies generated by DNA immunization recognize CD2 from a broad range of primates","volume":"87","author":"Brady","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2016.11.035_bb0325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/hum.2011.092","article-title":"Genetic immunization with plasmid DNA mediated by electrotransfer","volume":"22","author":"Rochard","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.intimp.2016.11.035_bb0330","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-5699(94)90006-X","article-title":"The immunobiology of muscle","volume":"15","author":"Hohlfeld","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.intimp.2016.11.035_bb0335","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1073\/pnas.91.20.9519","article-title":"Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses","volume":"91","author":"Raz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2016.11.035_bb0340","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm1096-1122","article-title":"DNA-based immunization by in vivo transfection of dendritic cells","volume":"2","author":"Condon","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2016.11.035_bb0345","first-page":"71","article-title":"DNA immunization as an efficient strategy for vaccination","volume":"1","author":"Bolhassani","year":"2009","journal-title":"Avicenna J. Med. Biotechnol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691630491X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691630491X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T06:08:50Z","timestamp":1692598130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691630491X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":69,"alternative-id":["S156757691630491X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.11.035","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}